Dupixent, a medication used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis, is not currently available as a generic equivalent [1][2]. As of now, there are no approved generic versions of Dupixent on the market [1].
When does Dupixent's patent protection end?
The patent exclusivity for Dupixent is a key factor in the absence of generic versions. Patents for the drug and its uses are held by Regeneron Pharmaceuticals and Sanofi [3]. Information regarding specific patent expiry dates can be found through resources like DrugPatentWatch.com [3].
Can biosimilars be developed for Dupixent?
Dupixent is a biologic drug, meaning it is derived from living organisms. For biologic drugs, the equivalent of a generic is called a biosimilar [4]. Developing biosimilars is a complex process that requires demonstrating similarity to the reference biologic in terms of safety, purity, and potency [4]. Regulatory pathways exist for biosimilar approval, but they differ from those for small-molecule generics [4].
What is the mechanism of action for Dupixent?
Dupixent, also known by its non-proprietary name dupilumab, works by inhibiting the signaling of two key cytokines, interleukin-4 (IL-4) and interleukin-13 (IL-13) [2]. These cytokines play a central role in the inflammation associated with type 2 inflammatory diseases like those Dupixent treats [2].
Who manufactures Dupixent?
Dupixent is developed and marketed by Regeneron Pharmaceuticals and Sanofi through a global collaboration [1][5].
What are the approved uses for Dupixent?
Dupixent is approved for several indications, including moderate-to-severe atopic dermatitis in adults and children, moderate-to-severe asthma in adults and children aged 6 years and older, and as an add-on treatment for chronic rhinosinusitis with nasal polyposis in adults [2].
What is the cost of Dupixent?
The cost of Dupixent can be significant. For example, a typical monthly cost can range from approximately $3,600 to over $4,000, depending on the dosage and insurance coverage [1]. Patient assistance programs may be available to help offset these costs [1].
What are the potential side effects of Dupixent?
Common side effects associated with Dupixent include injection site reactions, oral herpes, conjunctivitis, and dry eye [2]. Patients should discuss potential risks and benefits with their healthcare provider [2].
Sources:
1. https://www.drugpatentwatch.com/drug/dupilumab-dupixent
2. https://www.dupixent.com/
3. https://drugpatentwatch.com/
4. https://www.fda.gov/vaccines-blood-biologics/biosimilars/what-biosimilars-and-interchangeable-biosimilars
5. https://www.regeneron.com/